Northern Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91M | Sell |
|
|||||
|
2025
Q1 | $120M | Sell |
|
|||||
|
2024
Q4 | $113M | Buy |
|
|||||
|
2024
Q3 | $104M | Sell |
|
|||||
|
2024
Q2 | $130M | Buy |
|
|||||
|
2024
Q1 | $94.2M | Sell |
|
|||||
|
2023
Q4 | $111M | Sell |
|
|||||
|
2023
Q3 | $108M | Buy |
|
|||||
|
2023
Q2 | $102M | Sell |
|
|||||
|
2023
Q1 | $127M | Buy |
|
|||||
|
2022
Q4 | $135M | Buy |
|
|||||
|
2022
Q3 | $110M | Sell |
|
|||||
|
2022
Q2 | $108M | Sell |
|
|||||
|
2022
Q1 | $102M | Sell |
|
|||||
|
2021
Q4 | $120M | Buy |
|
|||||
|
2021
Q3 | $105M | Buy |
|
|||||
|
2021
Q2 | $107M | Buy |
|
|||||
|
2021
Q1 | $91.7M | Buy |
|
|||||
|
2020
Q4 | $104M | Sell |
|
|||||
|
2020
Q3 | $92.9M | Sell |
|
|||||
|
2020
Q2 | $160M | Buy |
|
|||||
|
2020
Q1 | $103M | Buy |
|
|||||
|
2019
Q4 | $96.3M | Sell |
|
|||||
|
2019
Q3 | $80.4M | Sell |
|
|||||
|
2019
Q2 | $104M | Buy |
|
|||||
|
2019
Q1 | $107M | Buy |
|
|||||
|
2018
Q4 | $101M | Buy |
|
|||||
|
2018
Q3 | $107M | Sell |
|
|||||
|
2018
Q2 | $104M | Buy |
|
|||||
|
2018
Q1 | $88.9M | Sell |
|
|||||
|
2017
Q4 | $99M | Buy |
|
|||||
|
2017
Q3 | $103M | Buy |
|
|||||
|
2017
Q2 | $99.7M | Buy |
|
|||||
|
2017
Q1 | $93.6M | Buy |
|
|||||
|
2016
Q4 | $86.1M | Sell |
|
|||||
|
2016
Q3 | $120M | Buy |
|
|||||
|
2016
Q2 | $94.2M | Buy |
|
|||||
|
2016
Q1 | $103M | Buy |
|
|||||
|
2015
Q4 | $119M | Sell |
|
|||||
|
2015
Q3 | $127M | Sell |
|
|||||
|
2015
Q2 | $175M | Sell |
|
|||||
|
2015
Q1 | $166M | Buy |
|
|||||
|
2014
Q4 | $117M | Buy |
|
|||||
|
2014
Q3 | $90.6M | Buy |
|
|||||
|
2014
Q2 | $63.5M | Sell |
|
|||||
|
2014
Q1 | $98.9M | Buy |
|
|||||
|
2013
Q4 | $83.8M | Buy |
|
|||||
|
2013
Q3 | $80.9M | Buy |
|
|||||
|
2013
Q2 | $62.2M | Buy |
|